202 related articles for article (PubMed ID: 24788042)
21. Mechanisms of heparanase inhibitors in cancer therapy.
Heyman B; Yang Y
Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
[TBL] [Abstract][Full Text] [Related]
22. Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells.
Masola V; Gambaro G; Tibaldi E; Brunati AM; Gastaldello A; D'Angelo A; Onisto M; Lupo A
J Biol Chem; 2012 Jan; 287(2):1478-88. PubMed ID: 22102278
[TBL] [Abstract][Full Text] [Related]
23. The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy.
Yang Y; MacLeod V; Dai Y; Khotskaya-Sample Y; Shriver Z; Venkataraman G; Sasisekharan R; Naggi A; Torri G; Casu B; Vlodavsky I; Suva LJ; Epstein J; Yaccoby S; Shaughnessy JD; Barlogie B; Sanderson RD
Blood; 2007 Sep; 110(6):2041-8. PubMed ID: 17536013
[TBL] [Abstract][Full Text] [Related]
24. Mapping heparanase expression in the spinal cord of adult rats.
Zhang Y; Yeung MN; Liu J; Chau CH; Chan YS; Shum DK
J Comp Neurol; 2006 Jan; 494(2):345-57. PubMed ID: 16320243
[TBL] [Abstract][Full Text] [Related]
25. The oligomeric status of syndecan-4 regulates syndecan-4 interaction with alpha-actinin.
Choi Y; Kim S; Lee J; Ko SG; Lee W; Han IO; Woods A; Oh ES
Eur J Cell Biol; 2008 Oct; 87(10):807-15. PubMed ID: 18621433
[TBL] [Abstract][Full Text] [Related]
26. Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis.
Kelly T; Suva LJ; Nicks KM; MacLeod V; Sanderson RD
J Bone Miner Res; 2010 Jun; 25(6):1295-304. PubMed ID: 20200931
[TBL] [Abstract][Full Text] [Related]
27. Involvement of Syndecan-1 and Heparanase in Cancer and Inflammation.
Teixeira FCOB; Götte M
Adv Exp Med Biol; 2020; 1221():97-135. PubMed ID: 32274708
[TBL] [Abstract][Full Text] [Related]
28. Heparanase-2 and syndecan-1 in colon cancer: the ugly ducklings or the beautiful swans?
Giordano RJ
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):716-8. PubMed ID: 18528290
[TBL] [Abstract][Full Text] [Related]
29. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.
Baietti MF; Zhang Z; Mortier E; Melchior A; Degeest G; Geeraerts A; Ivarsson Y; Depoortere F; Coomans C; Vermeiren E; Zimmermann P; David G
Nat Cell Biol; 2012 Jun; 14(7):677-85. PubMed ID: 22660413
[TBL] [Abstract][Full Text] [Related]
30. New structural insight of C-terminal region of Syntenin-1, enhancing the molecular dimerization and inhibitory function related on Syndecan-4 signaling.
Choi Y; Yun JH; Yoo J; Lee I; Kim H; Son HN; Kim IS; Yoon HS; Zimmermann P; Couchman JR; Cho HS; Oh ES; Lee W
Sci Rep; 2016 Nov; 6():36818. PubMed ID: 27830760
[TBL] [Abstract][Full Text] [Related]
31. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
Han J; Hiebert LM
Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
[TBL] [Abstract][Full Text] [Related]
32. Incorporation, intracellular trafficking and processing of extracellular heparanase by mast cells: Involvement of syndecan-4-dependent pathway.
Higashi N; Waki M; Sudo Y; Suzuki S; Oku T; Tsuiji M; Tsuji T; Miyagishi M; Takahashi K; Nakajima M; Irimura T
Biochem Biophys Res Commun; 2018 Sep; 503(4):3235-3241. PubMed ID: 30149916
[TBL] [Abstract][Full Text] [Related]
33. Heparanase Mediates Intestinal Inflammation and Injury in a Mouse Model of Sepsis.
Chen S; He Y; Hu Z; Lu S; Yin X; Ma X; Lv C; Jin G
J Histochem Cytochem; 2017 Apr; 65(4):241-249. PubMed ID: 28170292
[TBL] [Abstract][Full Text] [Related]
34. Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans.
Gingis-Velitski S; Zetser A; Kaplan V; Ben-Zaken O; Cohen E; Levy-Adam F; Bashenko Y; Flugelman MY; Vlodavsky I; Ilan N
J Biol Chem; 2004 Oct; 279(42):44084-92. PubMed ID: 15292202
[TBL] [Abstract][Full Text] [Related]
35. High heparanase activity in multiple myeloma is associated with elevated microvessel density.
Kelly T; Miao HQ; Yang Y; Navarro E; Kussie P; Huang Y; MacLeod V; Casciano J; Joseph L; Zhan F; Zangari M; Barlogie B; Shaughnessy J; Sanderson RD
Cancer Res; 2003 Dec; 63(24):8749-56. PubMed ID: 14695190
[TBL] [Abstract][Full Text] [Related]
36. Heparanase processing by lysosomal/endosomal protein preparation.
Cohen E; Atzmon R; Vlodavsky I; Ilan N
FEBS Lett; 2005 Apr; 579(11):2334-8. PubMed ID: 15848168
[TBL] [Abstract][Full Text] [Related]
37. Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity.
Ramani VC; Yang Y; Ren Y; Nan L; Sanderson RD
J Biol Chem; 2011 Feb; 286(8):6490-9. PubMed ID: 21131364
[TBL] [Abstract][Full Text] [Related]
38. Heparanase: busy at the cell surface.
Fux L; Ilan N; Sanderson RD; Vlodavsky I
Trends Biochem Sci; 2009 Oct; 34(10):511-9. PubMed ID: 19733083
[TBL] [Abstract][Full Text] [Related]
39. Syndecan-1 ectodomain shedding is regulated by the small GTPase Rab5.
Hayashida K; Stahl PD; Park PW
J Biol Chem; 2008 Dec; 283(51):35435-44. PubMed ID: 18957427
[TBL] [Abstract][Full Text] [Related]
40. Processing and activation of latent heparanase occurs in lysosomes.
Zetser A; Levy-Adam F; Kaplan V; Gingis-Velitski S; Bashenko Y; Schubert S; Flugelman MY; Vlodavsky I; Ilan N
J Cell Sci; 2004 May; 117(Pt 11):2249-58. PubMed ID: 15126626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
